Left Main Percutaneous Coronary Revascularization

Left main (LM) coronary artery disease accounts for approximately 4-6% of all percutaneous coronary interventions (PCIs). There has been mounting evidence indicating the non-inferiority of LM PCI as a revascularization option, particularly for those with a low SYNTAX score. The EXCEL and NOBEL trial...

Full description

Saved in:
Bibliographic Details
Published in:US cardiology (Print) 2023, Vol.17, p.e09
Main Authors: Almoghairi, Abdulrahman, Al-Asiri, Nayef, Aljohani, Khalid, AlSaleh, Ayman, Alqahtani, Nasser G, Alasmary, Mohammed, Alali, Rudaynah, Tamam, Khaled, Alasnag, Mirvat
Format: Article
Language:English
Subjects:
Interventional Cardiology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Left main (LM) coronary artery disease accounts for approximately 4-6% of all percutaneous coronary interventions (PCIs). There has been mounting evidence indicating the non-inferiority of LM PCI as a revascularization option, particularly for those with a low SYNTAX score. The EXCEL and NOBEL trials have shaped current guidelines. The European Society of Cardiology assigned a class 2a (level of evidence B) for isolated LM disease involving the shaft and ostium and a class IIb (level of evidence B) for isolated LM disease involving the bifurcation or additional two- or three-vessel disease and a SYNTAX score
ISSN:1758-3896
1758-390X
1758-390X
DOI:10.15420/usc.2022.24